Back to results
US 10,694,761 B2Granted
Chocolate mass
OwnerJohannes Coyinventor
Life of this patent
Estimating the term…
Abstract
The invention provides a novel chocolate mass which has a glycemic index of less than 29 (GI<29) and of which the content of added sugar comprises at least 10% galactose and in addition a content of iosmaltulose and/or tagatose. The chocolate mass additionally has a content of vitamin E in the form of a tocotrienol-tocopherol mixture from natural sources, wherein the content of tocotrienols in the chocolate mass is greater than the content of tocopherols.
Claims24
A chocolate mass comprising:
- a cocoa mass,
- a combination of sugars comprising at least:
- i) galactose in form of a monosaccharide and wherein the galactose constitutes at least 10% of a total content of added sugars of the chocolate mass,
- ii) tagatose and/or isomaltulose, and
- iii) a tocotrienol-tocopherol mixture, wherein a ratio of tocotrienols to tocopherols in the tocotrienol-tocopherol mixture is greater than 1,
- wherein
- each of the sugars in the combination of sugars has a glycemic index of less than 35 (GI<35),
- all of the sugars in the combination of sugars together have a glycemic index of less than 29 (GI<29), and
- the chocolate mass has a glycemic index of less than 29 (GI<29),
- wherein the tocotrienol-tocopherol mixture is provided in an amount effective to suppress formation of reactive oxygen species by the galactose.
7 more elements
A method for therapeutic treatment of illnesses, the method comprising:
- providing the chocolate mass comprising
- a cocoa mass,
- sugars comprising:
- galactose in form of a monosaccharide and wherein said galactose constitutes at least 10% of a total content of added sugars of the chocolate mass, tagatose and/or isomaltulose,
- and a tocotrienol-tocopherol mixture, wherein a ratio of tocotrienols to tocopherols is greater than 1, wherein the tocotrienol-tocopherol mixture is provided in an amount effective to counteract formation of reactive oxygen species by the galactose, wherein each of the sugars has a glycemic index of less than 35 (GI<35), all of the sugars have a glycemic index of less than 29 (GI<29), and the chocolate mass has a glycemic index of less than 29 (GI<29);
- and
- administering to an individual in need of the therapeutic treatment of illnesses said chocolate mass, wherein said illness is celiac disease, type 2 diabetes mellitus, neurodegenerative diseases, tumors, illnesses that lead to cachexia (wasting syndrome), wherein said illnesses accompany inflammatory processes or are caused thereby and intestinal diseases.
4 more elements
Dependencies are inferred from the claim text.